Connect your AI

Teleflex TFX Restricted cash equivalents included in Other long-term assets

Restricted cash equivalents included in Other long-term assets at other companies

Boston ScientificBSX

——

Other financials

Income statement

Revenue$548.3M+32.3%

Gross profit$307.4M+20.4%

Operating income$20.2M-73.4%

Net income-$8.2M-109%

EPS (diluted)-$0.18-109%

Balance sheet

Cash & equivalents$329.6M+16.8%

Total debt$2.8B+38.6%

Total equity$3.1B-24.7%

Total assets$6.8B-5.3%

Cash flow

Operating cash flow$46.7M+68.3%

CapEx$18.8M-22.1%

Free cash flow$27.9M+676%

Valuation

Market cap$5.62B-14.4%

Enterprise value$8.07B-2.0%

P/S2.6×-1.2×

Profitability

Gross margin38.2%-3.0pp

Operating margin3%-11.8pp

Net margin-47.4%-56.2pp

FCF margin7.9%—

Returns & leverage

Return on equity-28.1%-31.6pp

Debt / equity0.9×+0.4×

Current ratio2.6×+0.3×

Where this comes from

Reported directly by Teleflex in its filing.

Tagged under the XBRL concept us-gaap:RestrictedCashEquivalentsNoncurrent.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's restricted cash equivalents included in other long-term assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Teleflex's restricted cash equivalents included in other long-term assets?: Teleflex (TFX) reported restricted cash equivalents included in other long-term assets of $5.44M in Q1 2026.
How has Teleflex's restricted cash equivalents included in other long-term assets changed year-over-year?: Teleflex's restricted cash equivalents included in other long-term assets decreased by 70.8% year-over-year, from $18.66M to $5.44M.